E-Health: Hospitals likely to become “aggregators of connected objects” | L’Atelier: Disruptive innovation

Connected objects are likely to become increasingly ever-present in healthcare, both in the patient’s everyday environment and directly on and inside their bodies.

Interview with Yuri Van Geest, co-founder of Quantified Self Europe and ambassador of the Netherlands at the Singularity University, conducted ahead of his presentation entitled ‘Sensors & Tracking: Quantifying the Self & Listening to Your Body’ at the Health 2.0 Europe event held in London on 17 – 19 November.

We’re seeing more and more connected objects appearing in the fields of fitness and wellness. How do you see this market going forward?

These things are going to become more and more integrated. We’re going to see a lot more connected objects appearing for use directly inside people’s bodies with the aim of preventing illness – to anticipate heart attacks for instance. And there’ll be a strong drive towards mobile, for both general well-being and health. It will be possible to analyse on the one hand your external environment – your food, vitamins, or identify toxins present in foodstuffs, and on the other hand what’s inside your own body – your DNA plus also glucose level, the bacteria in your mouth, your nose, on your skin, and so on.

Will the medical sector – hospitals, the pharmaceutical industry, plus insurance companies, etc – be able to obtain a share in this market?

I think that will be difficult because this is an extremely competitive market. Rather than trying to compete, I feel rather that the medical sector will in the years to come play a complementary role. But for that to happen, the players will have to reinvent their business model. Hospitals will in any case have to do so, from the point of view of preventive medicine, which will call for centralisation of these technologies. But then of course the hospitals will have to be allowed to take on this role, which will depend to a large extent on the insurance system. However, the main obstacle facing this sector will be user experience. They’ll have to provide better, more precise data. A change on the legal side will also be vital here, especially as regards personal data security. For example it will be essential to ban right away any discrimination by insurance companies on the basis of personal medical data. But if they are going to get around these obstacles the most important thing is not so much to change the business model as to move to a ‘research model’.

See on www.atelier.net

From Pharmaceutical Industry digital vision

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s